Chemopreventive promise of targeting the Nrf2 pathway

被引:48
|
作者
Yates, Melinda S.
Kensler, Thomas W.
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1358/dnp.2007.20.2.1083437
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Kelch ECH associating protein 1-nuclear factor-E2-related factor 2-antioxidant response element (Keap 1-Nrf2-ARE) signaling pathway regulates several protective mechanisms including expression of conjugating and antioxidative genes, antiinflammatory responses, the molecular chaperone/stress response system and the ubiquitin/proteasome system. The Nrf2-mediated response alters susceptibility to carcinogenesis, acute chemical toxicity, oxidative stress, asthma, acute inflammation, septic shock and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Studies using natural and synthetic chemical inducers that activate Nrf2 signaling have demonstrated protective efficacy in many animal models of disease. Conversely, studies in Nrf2-disrupted mice indicate they exhibit increased sensitivity to many of these diseases. Thus, activation of Keap1-Nrf2-ARE signaling constitutes a broad protective response, making Nrf2 and its interacting partners important targets for chemoprevention. However, additional studies are needed to characterize Keap1-Nrf2-ARE signaling in humans to further develop exceptionally potent activators of the pathway and further understand the potential consequences of altering this system. (c) 2007 Prous Science. All rights reserved.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 50 条
  • [1] Dietary Cancer Chemopreventive Agents - Targeting Inflammation and Nrf2 Signaling Pathway
    Khor, Tin Oo
    Yu, Siwang
    Kong, Ah-Ng
    [J]. PLANTA MEDICA, 2008, 74 (13) : 1540 - 1547
  • [2] High-throughput screening of chemopreventive compounds targeting Nrf2
    Villeneuve, Nicole F.
    Du, Yu
    Wang, Xiao-Jun
    Sun, Zheng
    Zhang, Donna D.
    [J]. 2008 3RD IEEE INTERNATIONAL CONFERENCE ON NANO/MICRO ENGINEERED AND MOLECULAR SYSTEMS, VOLS 1-3, 2008, : 1138 - 1141
  • [3] Development of a Molecular Assay for Rapid Screening of Chemopreventive Compounds Targeting Nrf2
    Wang, Zhaohui
    Gidwani, Vinay
    Sun, Zheng
    Zhang, Donna D.
    Wong, Pak Kin
    [J]. JALA - Journal of the Association for Laboratory Automation, 2008, 13 (04): : 243 - 248
  • [4] Targeting the Nrf2 pathway against cardiovascular disease
    Li, Jinqing
    Ichikawa, Tomonaga
    Janicki, Joseph S.
    Cui, Taixing
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 785 - 794
  • [5] Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
    Telkoparan-Akillilar, Pelin
    Panieri, Emiliano
    Cevik, Dilek
    Suzen, Sibel
    Saso, Luciano
    [J]. MOLECULES, 2021, 26 (05):
  • [6] TARGETING THE Keap1/Nrf2 PATHWAY FOR CHEMOPROTECTION
    Dinkova-Kostova, Albena
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2014, 76 : S5 - S5
  • [7] The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
    Bhandari, Ranjana
    Kaur, Japneet
    Kaur, Simerpreet
    Kuhad, Anurag
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (02) : 115 - 139
  • [8] KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
    Dinkova-Kostova, Albena T.
    Fahey, Jed W.
    Kostov, Rumen V.
    Kensler, Thomas W.
    [J]. TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2017, 69 : 257 - 269
  • [9] KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
    Kensler, Thomas
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [10] An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis
    Saha, Sarmistha
    [J]. ACS OMEGA, 2024, 9 (09): : 10049 - 10057